AGI Group acquires Chemtrix B.V. to expand into the large-scale flow chemistry market
AGI Group is excited to announce the successful acquisition of Chemtrix B.V. effective from 29th December 2023. Chemtrix, based in the Netherlands, designs and manufactures a scalable portfolio of flow reactors that enables industry and academia to harness the advantages of flow chemistry and process intensification. This strategic acquisition will bring flow chemistry scale-up capabilities into the AGI Group, supporting both pilot and manufacturing solutions.
The AGI Group, founded in Japan, is a world-leading solutions provider for precision manufactured glass equipment across chemical processing industries, including the scientific and pharmaceuticals sectors. The core strategy of the AGI Group is to expand its global presence to support customers and enable sales growth in markets outside of Japan.
The AGI Group’s exciting and expanding portfolio of well-known brands includes the flagship AGI Glassplant brand; Premex Reactor, a supplier of premium quality, high pressure reactor systems and magnetic stirrers for research and development; and Syrris, the global leader in flow chemistry solutions for laboratory scale applications.
The Chemtrix flow reactor portfolio complements these offerings perfectly and has been designed to change how chemical processes are developed, delivering increased process safety, reduced operating costs and new chemical possibilities at scales ranging from milligrams in the lab through to tonnes for manufacturing.
Mike Hawes, CEO of AGI International, commented: “We are very excited to have Chemtrix join AGI Group. We have a strong and successful history in providing high performance flow chemistry solutions for research laboratories. The addition of Chemtrix now allows us to support the market in scaling up their processes to the pilot plant and manufacturing scales. Chemtrix has a fantastic reputation in this market, and we are delighted to be able to offer the high quality and high-performance solutions in the Chemtrix portfolio.”
Dr. Charlotte Wiles, CEO of Chemtrix, commented: “Our strategy focusses on developing close collaborations with end users across academia, the fine chemicals, specialty chemicals and pharmaceuticals industries to develop a complete, easy to scale product portfolio whilst delivering our customers safe and reliable scale-up from the lab to industrial production. We are delighted to join AGI Group, and continue our shared mission of delivering high quality, efficient solutions that meet our customers challenging process needs.”
Comments